Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Jan 12, 2016
DelveInsight, the leading market research and consulting company has added new report Peripheral Lung Cancer-Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clients with up to date inf...
Read More...
Sep 01, 2015
Introduction A disease that has not been adopted by the pharmaceutical industry because it provides little financial incentive for the private sector to make and market new medications to treat or prevent it. An orphan disease may be a rare disease or a common disease that has been ignored because it is far more pr...
Read More...
Mar 18, 2015
Launch of DelveInsight’s Antibody-Drug Conjugate Report DelveInsight’s Antibody-Drug Conjugate: Global Market and Pipeline Outlook, 2015, report provides the information across the ADCs drug value chain. The Report provides the marketed and pipeline scenario of the ADCs. The Report has covered the 264 Antibody-dr...
Read More...
Jan 08, 2015
Only a hundred and fifty years have passed since Gregor Mendel’s discovery of simple Mendelian inheritance. In a remarkably short amount of time humans have achieved such impressive feats as sequencing the entire human genome and gaining understanding of the causes of most genetic disease. Now that researchers have ...
Read More...
Jan 06, 2015
Gene Therapy: The “Big Value” Market! Gene therapy has been under scientific research for over 2 decades, but viable therapies have yet to gain commercial acceptance due to safety and delivery-related issues. However, Pfizer’s move and some other recent developments in the industry suggest that the therapy may be ...
Read More...
Dec 30, 2014
Gene Therapy: Eye for the cure! Recent technical advances have led to the demonstration of the molecular basis of various ocular diseases. Gene transfer into ocular tissues has been demonstrated with growing functional success and may develop into a new therapeutic tool for clinical ophthalmology. There are pr...
Read More...
Dec 30, 2014
Gene Therapy to “target” Hematological disorders! About Hematological disorders Hematology is the study of blood in health and disease. It includes problems with the red blood cells, white blood cells, platelets, blood vessels, bone marrow, lymph nodes, spleen, and the proteins involved in bleeding and clotting (h...
Read More...
Dec 30, 2014
Gene Therapy’s “expanding” role in Respiratory disorders! About Respiratory disorders Respiratory disorders encompasses pathological conditions affecting the organs and tissues that make gas exchange possible in higher organisms, and includes conditions of the upper respiratory tract, trachea, bronchi, bronchioles...
Read More...
Dec 29, 2014
Gene Therapy: The “Hope” for Immunologic disorders! About Immunologic disorders Immunological disorders are a dysfunction of the immune system. These disorders cause abnormally low activity or overactivity of the immune system. In cases of immune system overactivity, the body attacks and damages its own tissues. T...
Read More...
Dec 29, 2014
Gene Therapy to “heal” Cardiovascular disorders! Coronary artery disease, heart failure, and cardiac arrhythmias are major causes of morbidity and mortality in the developed countries. Pharmacologic drugs and device therapies have multiple limitations, and there exists an unmet need for improved clinical outcomes ...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper